FDA PMA FDA Class 3 Approved 🇺🇸 United States

System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection

PMA: P230001 · Supplement: S008 · Decision Jul 3, 2025
Classifications
1
FEI Numbers
2
Registration Numbers
2

Basic Information

Device Name
System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection
Trade Name
ColoSense®
PMA Number
P230001
Supplement Number
S008
Device Class
FDA Class 3
Product Code
SBB
Generic Name
System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection
Medical Specialty
Unknown
Advisory Committee
Pathology
Decision
Approved
Decision Code
APPR
Decision Date
July 3, 2025
Date Received
January 29, 2025
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

approval for a change in the contract packaging site location for the ColoSense Collection Kit

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
SBB System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection